Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 2Dermatologic 1

Conditions

Sezary Syndrome 2Mycosis Fungoides 1Melanoma 1Lymphoma, T-Cell, Cutaneous 1Hepatitis 1Graft vs Host Disease 1Colitis 1Bronchiolitis Obliterans Syndrome 1

Interventions

mogamulizumab 4Specimen Handling 3Immunoglobulin G 3Disulfides 3Cyclophosphamide 3Biopsy 3pembrolizumab 2fludarabine phosphate 2fludarabine 2Whole-Body Irradiation 2Tacrolimus 2Photopheresis 2Peripheral Blood Stem Cell Transplantation 2Nivolumab 2Mycophenolic Acid 2Magnetic Resonance Spectroscopy 2Busulfan 2Blood Specimen Collection 2talimogene laherparepvec 1magrolimab 1duvelisib 1durvalumab 1Vincristine 1Valganciclovir 1Urine Specimen Collection 1Transplantation 1Therapeutics 1Sirolimus 1Radiotherapy 1Prednisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Sezary Syndrome × Photopheresis × 1 year × Clear all
NCT05157581 2025-12-30

ECP

University of Pittsburgh

Recruiting
20 enrolled
Lymphoid

Sezary Syndrome

NCT04930653 2025-10-14

Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma

City of Hope Medical Center

Phase 2 Recruiting
34 enrolled
DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡